Pfizer says jab 100% effective in 12- to 15-year-olds
Pfizer and BioNTech said on Wednesday their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year olds, paving the way for them to seek U.S. emergency use authorization in weeks.
